Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Tech Transfer Roundup: Tmunity Targets Pediatric Glioma With UCSF-Discovered TCR Therapy

May 01 2019

• By Joseph Haas

Tech Transfer regular column feature image

Related Content

Finance Watch: Flagship Raises $824m To Speed Growth Of Its Portfolio Companies

Mar 22 2019

Tmunity Raises $100m Series A To Fund Next-Gen T-Cell Therapy Trials

Jan 24 2018

Related Companies

Tmunity Therapeutics Inc.

University of California San Francisco

University of Pennsylvania

Bayer AG

Hope Medicine Inc.

Wisconsin Alumni Research Foundation

Sanford Burnham Prebys Medical Discovery Institute

University of Wisconsin system

Astellas Gene Therapies

Nationwide Children’s Hospital

Centene Corporation

Washington University School of Medicine

University of California, Los Angeles

Bausch Health Companies Inc.

Salix Pharmaceuticals Ltd.

Xilio Therapeutics, Inc.

Thomas Jefferson University

Sana Biotechnology, Inc.

Bristol Myers Squibb Company

Harvard University

Bristol Myers Squibb Company

Hoth Therapeutics, Inc.

University of Maryland, Baltimore

Isoprene Pharmaceuticals, Inc.

OncoTracker Inc.

Institute for Myeloma & Bone Cancer Research

Qualigen Therapeutics, Inc.

University of Louisville

Institut Pasteur

University of Oxford

OSE Immunotherapeutics

Pierre Fabre

Institut Curie

Enterome SA

Dana-Farber/Harvard Cancer Center

Pascal Biosciences Inc.

The University of British Columbia

Weill Cornell Medical College

Seelos Therapeutics, Inc.

Additional Topics

Research & Development Deals Intellectual Property Business Strategies BioPharmaceutical

More from R&D

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window